Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07827144 |
| Title | A Study to Test How Well Different Doses of BI 4060107 Are Tolerated by People With Advanced Cancer (Solid Tumours) |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | AIMEDBIO |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | FRA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Texas Oncology - Irving | Irving | Texas | 75039 | United States | Details | |
| Austin Health | Heidelberg | Victoria | 3048 | Australia | Details | |
| Institut Gustave Roussy | Villejuif | 94800 | France | Details | ||
| National Cancer Center Hospital | Tokyo, Chuo-ku | 104-0045 | Japan | Details | ||
| Seoul National University Hospital | Seoul | 03080 | South Korea | Details | ||
| Samsung Medical Center | Seoul | 06351 | South Korea | Details |